Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?

Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?

Abstract Background The advent of therapeutic strategies designed to modify the disease course in Parkinson’s disease has raised great expectations in the currently conducted clinical trials. However, we see ethical challenges in the cooperation of industry and clinical partners, specifically eviden...

Full description

Bibliographic Details
Main Authors: D. Berg, K. Eggert, B. Haslinger, J. Kassubek, B. Mollenhauer, K. Reetz, A. Rogge, E. Schaeffer, L. Tönges, K. E. Zeuner
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Neurological Research and Practice
Subjects:
Parkinson’s Disease
Disease modifying treatments
Clinical trials
Ethical challenges
Online Access:http://link.springer.com/article/10.1186/s42466-020-00076-y

Internet

http://link.springer.com/article/10.1186/s42466-020-00076-y

Similar Items